Insmed Inc INSM

NAS: INSM | ISIN: US4576693075 21/10/2025

165,31 USD (-1,55%)

(-1,55%) 21/10/2025

Grafiek Insmed Inc

Grafiek Insmed Inc

1 dag1d -1,55%
1 week1w 1,08%
1 maand1m 13,98%
3 maanden3m 60,62%
6 maanden6m 132,05%
1 jaar1j 124,36%
5 jaar5j 342,12%

donderdag 30 oktober 2025, 12:00

Kwartaalcijfers (3de kwartaal)

Insmed Inc in het nieuws

Toon enkel gratis nieuws

17 oktober 2025 · CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis · Persbericht

16 oktober 2025 · Insmed to Present Multiple Analyses from Phase 3 ASPEN Study at the American College of Chest Physicians Annual Meeting 2025 · Persbericht

15 oktober 2025 · Insmed to Host Third-Quarter 2025 Financial Results Conference Call on Thursday, October 30, 2025 · Persbericht

22 september 2025 · Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025 · Persbericht

5 september 2025 · Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

21 augustus 2025 · Insmed To Present at September Investor Conferences · Persbericht

12 augustus 2025 · FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease · Persbericht

7 augustus 2025 · Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update · Persbericht

4 augustus 2025 · Late-Stage Pipeline Wins Boost Investor Confidence in High-Growth Therapeutic Areas · Persbericht

24 juli 2025 · Insmed to Host Second-Quarter 2025 Financial Results Conference Call on Thursday, August 7, 2025 · Persbericht

Profiel Insmed Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.insmed.com

Hoofdzetel: Bridgewater, New Jersey Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe